We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.97%
AUM
$114M
AUM Growth
+$5.96M
Cap. Flow
+$1.42M
Cap. Flow %
1.24%
Top 10 Hldgs %
48.81%
Holding
78
New
3
Increased
13
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$5.07M
2
DXJ icon
WisdomTree Japan Hedged Equity Fund
DXJ
+$2.66M
3
GWX icon
State Street SPDR S&P International Small Cap ETF
GWX
+$1.51M
4
JD icon
JD.com
JD
+$970K
5
BABA icon
Alibaba
BABA
+$778K

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.22M
2
CSCO icon
Cisco
CSCO
+$2.07M
3
PFE icon
Pfizer
PFE
+$1.03M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$991K
5
MCK icon
McKesson
MCK
+$851K

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.97%
2 Consumer Discretionary 16.41%
3 Healthcare 15.86%
4 Communication Services 14.66%
5 Technology 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEWJ icon
26
iShares Currency Hedged MSCI Japan ETF
HEWJ
$746M
$1.22M 1.07%
41,000
– –
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$1.12M 0.98%
4,645
-1,319
-22% -$316K
XOM icon
28
ExxonMobil
XOM
$644B
$1.11M 0.98%
13,790
– –
IBM icon
29
IBM
IBM
$222B
$884K 0.77%
6,009
+219
+4% +$33K
DD icon
30
DuPont de Nemours
DD
$18.5B
$838K 0.73%
5,248
– –
RTX icon
31
RTX Corp
RTX
$285B
$741K 0.65%
9,648
– –
GXC icon
32
State Street SPDR S&P China ETF
GXC
$474M
$732K 0.64%
8,200
– –
VYM icon
33
Vanguard High Dividend Yield ETF
VYM
$82.8B
$713K 0.62%
9,120
– –
MCD icon
34
McDonald's
MCD
$188B
$689K 0.6%
4,500
– –
ABBV icon
35
AbbVie
ABBV
$451B
$683K 0.6%
9,416
-388
-4% -$26.1K
PG icon
36
Procter & Gamble
PG
$334B
$674K 0.59%
7,730
-36,492
-83% -$3.22M
WMT icon
37
Walmart Inc
WMT
$820B
$651K 0.57%
25,809
-2,754
-10% -$69.9K
IJH icon
38
iShares Core S&P Mid-Cap ETF
IJH
$124B
$611K 0.54%
17,575
– –
JPM icon
39
JPMorgan Chase
JPM
$951B
$509K 0.45%
5,567
– –
GILD icon
40
Gilead Sciences
GILD
$181B
$442K 0.39%
6,250
– –
INTC icon
41
Intel
INTC
$473B
$437K 0.38%
12,960
– –
MSFT icon
42
Microsoft
MSFT
$3.81T
$436K 0.38%
6,325
– –
UNFI icon
43
United Natural Foods
UNFI
$2.77B
$415K 0.36%
11,300
– –
EWU icon
44
iShares MSCI United Kingdom ETF
EWU
$3.81B
$400K 0.35%
+12,000
New +$403K
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$381K 0.33%
7,155
-122
-2% -$6.48K
TEF
46
DELISTED
Telefonica
TEF
$368K 0.32%
43,848
– –
ICLN icon
47
iShares Global Clean Energy ETF
ICLN
$2.19B
$352K 0.31%
41,130
– –
SNY icon
48
Sanofi
SNY
$107B
$352K 0.31%
7,340
– –
VOD icon
49
Vodafone
VOD
$37.1B
$331K 0.29%
11,510
– –
MAT icon
50
Mattel
MAT
$4.33B
$318K 0.28%
14,758
+27
+0.2% +$610
1
2
3 4

Similar funds

TAM
Third Avenue Management New York $625M AUM 48.93% 1-Year Est. Return
RIP
RAM Investment Partners Bellevue, Washington $625M AUM 16.29% 1-Year Est. Return
CWM
Chemistry Wealth Management New York $625M AUM 19.32% 1-Year Est. Return
LWP
LMG Wealth Partners Shreveport, Louisiana $626M AUM 36.27% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $626M AUM 33.6% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $626M AUM 199.29% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Bellecapital's Q2 2017 Portfolio in Review

As of Q2 2017, Bellecapital held 78 positions worth $114M, up 5.5% from $108M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bellecapital's Q2 2017 filing shows 3 new, 13 increased, 18 reduced and 7 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M. The largest sale was Procter & Gamble, an estimated $3.22M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bellecapital's largest Q2 2017 buy was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M.
  • Bellecapital added most to WisdomTree Japan Hedged Equity Fund in Q2 2017, an estimated $2.66M increase.
  • Bellecapital's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $3.22M.
  • Bellecapital fully exited Pfizer in Q2 2017, selling an estimated $1.03M.
  • Bellecapital's ten largest holdings make up 49% of its $114M portfolio in Q2 2017.
  • Bellecapital opened 3 new positions and closed 7 in Q2 2017.
  • Bellecapital's portfolio value rose 5.5% quarter-over-quarter to $114M.

Based on Bellecapital's 13F filing for Q2 2017, filed 26 Jul 2017.